首页 > 最新文献

In vivo最新文献

英文 中文
Quantification of Treatment Plan Deliverability in Breast Volumetric-modulated Arc Therapy With Agility Multi-leaf Collimator. 利用 Agility 多叶准直仪量化乳腺容积调制弧治疗中的治疗计划可送达性。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13690
DO Hoon Oh, Jin Hwa Choi, Hyejo Ryu, Minsoo Chun

Background/aim: The aim was to assess the complexity of breast volumetric-modulated arc therapy (VMAT) plans using various indices and to evaluate their performance through gamma analysis in predicting plan deliverability.

Materials and methods: A total of 285 VMAT plans for 260 patients were created using the VersaHD™ linear accelerator with a Monaco treatment planning system. Corresponding verification plans were generated using the ArcCHECK® detector, and gamma analysis was conducted employing various criteria. Twenty-eight plan complexity metrics were computed, and Pearson's correlation coefficients were determined between the gamma passing rate (GPR) and these metrics.

Results: The average GPR values for all plans were 97.7%, 89.9%, and 78.0% for the 2 mm/2%, 1 mm/2%, and 1 mm/1% criteria, respectively. While most complexity metrics exhibited weak correlations with GPRs under the 2 mm/2% criterion, leaf sequence variability (LSV), plan-averaged beam area (PA), converted area metric (CAM), and edge area metric (EAM) demonstrated the most robust performance, with Pearson's correlation coefficients of 0.57, 0.50, -0.70, and -0.56, respectively.

Conclusion: Metrics related to beam aperture size and irregularity, such as LSV, PA, CAM and EAM, proved to be reasonable predictors of plan deliverability in breast VMAT.

背景/目的:目的是使用各种指标评估乳腺容积调控弧治疗(VMAT)计划的复杂性,并通过伽马分析评估其在预测计划可实施性方面的性能:使用配备摩纳哥治疗计划系统的 VersaHD™ 直线加速器为 260 名患者创建了 285 个 VMAT 计划。使用 ArcCHECK® 探测器生成了相应的验证计划,并采用各种标准进行了伽马分析。计算了 28 个计划复杂度指标,并确定了伽马通过率(GPR)与这些指标之间的皮尔逊相关系数:结果:在 2 毫米/2%、1 毫米/2% 和 1 毫米/1% 标准下,所有计划的平均 GPR 值分别为 97.7%、89.9% 和 78.0%。虽然在 2 毫米/2% 标准下,大多数复杂度指标与 GPR 的相关性较弱,但叶序变异性 (LSV)、平面平均光束面积 (PA)、转换面积指标 (CAM) 和边缘面积指标 (EAM) 的表现最为稳健,皮尔逊相关系数分别为 0.57、0.50、-0.70 和 -0.56:与光束孔径大小和不规则性相关的指标,如 LSV、PA、CAM 和 EAM,被证明是乳腺 VMAT 中计划可交付性的合理预测指标。
{"title":"Quantification of Treatment Plan Deliverability in Breast Volumetric-modulated Arc Therapy With Agility Multi-leaf Collimator.","authors":"DO Hoon Oh, Jin Hwa Choi, Hyejo Ryu, Minsoo Chun","doi":"10.21873/invivo.13690","DOIUrl":"10.21873/invivo.13690","url":null,"abstract":"<p><strong>Background/aim: </strong>The aim was to assess the complexity of breast volumetric-modulated arc therapy (VMAT) plans using various indices and to evaluate their performance through gamma analysis in predicting plan deliverability.</p><p><strong>Materials and methods: </strong>A total of 285 VMAT plans for 260 patients were created using the VersaHD™ linear accelerator with a Monaco treatment planning system. Corresponding verification plans were generated using the ArcCHECK<sup>®</sup> detector, and gamma analysis was conducted employing various criteria. Twenty-eight plan complexity metrics were computed, and Pearson's correlation coefficients were determined between the gamma passing rate (GPR) and these metrics.</p><p><strong>Results: </strong>The average GPR values for all plans were 97.7%, 89.9%, and 78.0% for the 2 mm/2%, 1 mm/2%, and 1 mm/1% criteria, respectively. While most complexity metrics exhibited weak correlations with GPRs under the 2 mm/2% criterion, leaf sequence variability (LSV), plan-averaged beam area (PA), converted area metric (CAM), and edge area metric (EAM) demonstrated the most robust performance, with Pearson's correlation coefficients of 0.57, 0.50, -0.70, and -0.56, respectively.</p><p><strong>Conclusion: </strong>Metrics related to beam aperture size and irregularity, such as LSV, PA, CAM and EAM, proved to be reasonable predictors of plan deliverability in breast VMAT.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2254-2260"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Raepenol™ Cream, a Complex of Natural Compounds, Promotes Wound Healing and Relieves Pruritus In Vivo. Raepenol™ 乳霜是一种天然化合物复合物,可促进伤口愈合并缓解活体瘙痒。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13697
Eungyung Kim, Na Eun Cho, Sijun Park, Hong-Gyum Kim, Junkoo Yi, Hyeonjin Kim, Lei Ma, K E Huang, Zhibin Liu, Chae Yeon Kim, Kanghyun Park, Yonghun Sung, Soyoung Jang, Soyeon Jang, Seong-Kyoon Choi, Zae Young Ryoo, Su-Geun Lim, Myoung Ok Kim

Background/aim: Skin wound healing is a physiological process restoring the structural and functional integrity of injured skin. During this process, wound management preventing bacterial infection and complications is important for the regeneration of skin layers and adnexa, as well as the protective function of the skin. Therefore, the development of an effective ointment to promote wound healing without complications is beneficial.

Materials and methods: This study developed Raepenol™ cream, comprising a base cream and natural compounds including paeonol, D-panthenol and extract of Centella asiatica, and assessed its therapeutic effect in wound healing. A rat model of skin wound healing and a mouse model of imiquimod-induced pruritus were employed. The effect of Raepenol™ cream was evaluated by wound size and histological analysis, including the integrity of skin structures and inflammatory response.

Results: Raepenol™ cream treatment effectively restored the structural integrity of the skin in rats, including wound closure, regeneration of skin adnexa, and reconstitution of collagen, comparable to commercial ointment. Additionally, Raepenol™ cream significantly suppressed pruritus by inhibiting mast cell infiltration or retention in the inflammatory site of mouse ears.

Conclusion: Raepenol™ cream effectively promoted wound healing and relieved pruritus in animal models. These results suggest that it could be a promising option for wound care and pruritus relief, offering potential advantages over current ointments.

背景/目的:皮肤伤口愈合是一个恢复受伤皮肤结构和功能完整性的生理过程。在此过程中,防止细菌感染和并发症的伤口处理对皮肤层和附件的再生以及皮肤的保护功能非常重要。因此,开发一种能促进伤口愈合且无并发症的有效药膏是有益的:本研究开发了 Raepenol™ 乳膏,由基础乳膏和天然化合物(包括芍药酚、D-泛醇和积雪草提取物)组成,并评估了其对伤口愈合的治疗效果。实验采用了大鼠皮肤伤口愈合模型和小鼠咪喹莫特诱发瘙痒模型。通过伤口大小和组织学分析(包括皮肤结构的完整性和炎症反应)来评估雷贝诺™乳膏的效果:结果:雷贝诺乳膏能有效恢复大鼠皮肤结构的完整性,包括伤口闭合、皮肤附件再生和胶原蛋白重组,其效果与商业软膏相当。此外,雷贝诺™乳膏还能抑制肥大细胞在小鼠耳朵炎症部位的浸润或滞留,从而明显抑制瘙痒:结论:雷贝诺乳膏能有效促进动物模型的伤口愈合并缓解瘙痒。结论:雷贝诺乳膏能有效促进动物模型的伤口愈合并缓解瘙痒症状。这些结果表明,雷贝诺乳膏在伤口护理和缓解瘙痒方面很有前景,与现有的软膏相比具有潜在的优势。
{"title":"Raepenol™ Cream, a Complex of Natural Compounds, Promotes Wound Healing and Relieves Pruritus <i>In Vivo</i>.","authors":"Eungyung Kim, Na Eun Cho, Sijun Park, Hong-Gyum Kim, Junkoo Yi, Hyeonjin Kim, Lei Ma, K E Huang, Zhibin Liu, Chae Yeon Kim, Kanghyun Park, Yonghun Sung, Soyoung Jang, Soyeon Jang, Seong-Kyoon Choi, Zae Young Ryoo, Su-Geun Lim, Myoung Ok Kim","doi":"10.21873/invivo.13697","DOIUrl":"10.21873/invivo.13697","url":null,"abstract":"<p><strong>Background/aim: </strong>Skin wound healing is a physiological process restoring the structural and functional integrity of injured skin. During this process, wound management preventing bacterial infection and complications is important for the regeneration of skin layers and adnexa, as well as the protective function of the skin. Therefore, the development of an effective ointment to promote wound healing without complications is beneficial.</p><p><strong>Materials and methods: </strong>This study developed Raepenol™ cream, comprising a base cream and natural compounds including paeonol, D-panthenol and extract of Centella asiatica, and assessed its therapeutic effect in wound healing. A rat model of skin wound healing and a mouse model of imiquimod-induced pruritus were employed. The effect of Raepenol™ cream was evaluated by wound size and histological analysis, including the integrity of skin structures and inflammatory response.</p><p><strong>Results: </strong>Raepenol™ cream treatment effectively restored the structural integrity of the skin in rats, including wound closure, regeneration of skin adnexa, and reconstitution of collagen, comparable to commercial ointment. Additionally, Raepenol™ cream significantly suppressed pruritus by inhibiting mast cell infiltration or retention in the inflammatory site of mouse ears.</p><p><strong>Conclusion: </strong>Raepenol™ cream effectively promoted wound healing and relieved pruritus in animal models. These results suggest that it could be a promising option for wound care and pruritus relief, offering potential advantages over current ointments.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2318-2327"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silibinin Mitigates Vanadium-induced Lung Injury via the TLR4/MAPK/NF-κB Pathway in Mice. 水飞蓟宾通过TLR4/MAPK/NF-κB途径减轻钒诱发的小鼠肺损伤
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13681
Hobin Im, Eungyung Kim, Hong Ju Kwon, Hyeonjin Kim, Jiwon Ko, Yonghun Sung, Sung-Hyun Kim, Eun Jung Lee, Woo-Sung Kwon, Zae Young Ryoo, Junkoo Yi, Si Jun Park, Myoung Ok Kim

Background/aim: Silibinin, has been investigated for its potential benefits and mechanisms in addressing vanadium pentoxide (V2O5)-induced pulmonary inflammation. This study explored the anti-inflammatory activity of silibinin and elucidate the mechanisms by which it operates in a mouse model of vanadium-induced lung injury.

Materials and methods: Eight-week-old male BALB/c mice were exposed to V2O5 to induce lung injury. Mice were pretreated with silibinin at doses of 50 mg/kg and 100 mg/kg. Histological analyses were performed to assess cell viability and infiltration of inflammatory cells. The expression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) and activation of the MAPK and NF-[Formula: see text]B signaling pathways, as well as the NLRP3 inflammasome, were evaluated using real-time PCR, western blot analysis, and immunohistochemistry. Whole blood analysis was conducted to measure white blood cell counts.

Results: Silibinin treatment significantly improved cell viability, reduced inflammatory cell infiltration, and decreased the expression of pro-inflammatory cytokines in V2O5-induced lung injury. It also notably suppressed the activation of the MAPK and NF-[Formula: see text]B signaling pathways, along with a marked reduction in NLRP3 inflammasome expression levels in lung tissues. Additionally, silibinin-treated groups exhibited a significant decrease in white blood cell counts, including neutrophils, lymphocytes, and eosinophils.

Conclusion: These findings underscore the potent anti-inflammatory effects of silibinin in mice with V2O5-induced lung inflammation, highlighting its therapeutic potential. The study not only confirms the efficacy of silibinin in mitigating inflammatory responses but also provides a foundational understanding of its role in modulating key inflammatory pathways, paving the way for future therapeutic strategies against pulmonary inflammation induced by environmental pollutants.

背景/目的:人们一直在研究西利宾在解决五氧化二钒(V2O5)诱导的肺部炎症方面的潜在益处和机制。本研究探讨了水飞蓟宾的抗炎活性,并阐明了水飞蓟宾在钒诱导的肺损伤小鼠模型中的作用机制:将八周大的雄性 BALB/c 小鼠暴露于 V2O5 以诱导肺损伤。对小鼠进行50毫克/千克和100毫克/千克剂量的西利宾预处理。对小鼠进行组织学分析,以评估细胞存活率和炎症细胞浸润情况。使用实时 PCR、Western 印迹分析和免疫组织化学方法评估了促炎细胞因子(TNF-α、IL-6、IL-1β)的表达、MAPK 和 NF-[式中:见正文]B 信号通路以及 NLRP3 炎性体的激活情况。全血分析用于测量白细胞计数:结果:在 V2O5 引起的肺损伤中,西利宾处理能明显提高细胞活力,减少炎症细胞浸润,降低促炎细胞因子的表达。它还明显抑制了 MAPK 和 NF-[配 方:见正文]B 信号通路的激活,同时明显降低了肺组织中 NLRP3 炎性体的表达水平。此外,西利宾处理组的白细胞数量也明显减少,包括中性粒细胞、淋巴细胞和嗜酸性粒细胞:这些发现强调了西利宾对 V2O5 诱导的肺部炎症小鼠的强效抗炎作用,凸显了其治疗潜力。这项研究不仅证实了丝利宾在减轻炎症反应方面的功效,还为人们了解丝利宾在调节关键炎症通路方面的作用提供了基础,为未来针对环境污染物诱发的肺部炎症的治疗策略铺平了道路。
{"title":"Silibinin Mitigates Vanadium-induced Lung Injury <i>via</i> the TLR4/MAPK/NF-κB Pathway in Mice.","authors":"Hobin Im, Eungyung Kim, Hong Ju Kwon, Hyeonjin Kim, Jiwon Ko, Yonghun Sung, Sung-Hyun Kim, Eun Jung Lee, Woo-Sung Kwon, Zae Young Ryoo, Junkoo Yi, Si Jun Park, Myoung Ok Kim","doi":"10.21873/invivo.13681","DOIUrl":"10.21873/invivo.13681","url":null,"abstract":"<p><strong>Background/aim: </strong>Silibinin, has been investigated for its potential benefits and mechanisms in addressing vanadium pentoxide (V2O5)-induced pulmonary inflammation. This study explored the anti-inflammatory activity of silibinin and elucidate the mechanisms by which it operates in a mouse model of vanadium-induced lung injury.</p><p><strong>Materials and methods: </strong>Eight-week-old male BALB/c mice were exposed to V2O5 to induce lung injury. Mice were pretreated with silibinin at doses of 50 mg/kg and 100 mg/kg. Histological analyses were performed to assess cell viability and infiltration of inflammatory cells. The expression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) and activation of the MAPK and NF-[Formula: see text]B signaling pathways, as well as the NLRP3 inflammasome, were evaluated using real-time PCR, western blot analysis, and immunohistochemistry. Whole blood analysis was conducted to measure white blood cell counts.</p><p><strong>Results: </strong>Silibinin treatment significantly improved cell viability, reduced inflammatory cell infiltration, and decreased the expression of pro-inflammatory cytokines in V2O5-induced lung injury. It also notably suppressed the activation of the MAPK and NF-[Formula: see text]B signaling pathways, along with a marked reduction in NLRP3 inflammasome expression levels in lung tissues. Additionally, silibinin-treated groups exhibited a significant decrease in white blood cell counts, including neutrophils, lymphocytes, and eosinophils.</p><p><strong>Conclusion: </strong>These findings underscore the potent anti-inflammatory effects of silibinin in mice with V2O5-induced lung inflammation, highlighting its therapeutic potential. The study not only confirms the efficacy of silibinin in mitigating inflammatory responses but also provides a foundational understanding of its role in modulating key inflammatory pathways, paving the way for future therapeutic strategies against pulmonary inflammation induced by environmental pollutants.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2179-2189"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebral Angiography and Neurobehavioral Patterns in a Non-human Primate Middle Cerebral Artery Occlusion Model. 非人灵长类大脑中动脉闭塞模型的脑血管造影和神经行为模式
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13689
Tetsuya Yoshikawa, Yuki Akiyoshi, Kensei Motokawa, Koichiro Nojiri, Hiroaki Kawaguchi

Background/aim: Ischemic stroke is a major health concern globally and developing reliable animal models is crucial for understanding its pathophysiology. This study evaluated the relationship between cerebral angiographic findings and neurologic dysfunction in an acute non-human primate thromboembolic stroke model and determined the minimum clot length for suitable middle cerebral artery (MCA) occlusion.

Materials and methods: A thromboembolic stroke model was developed by injecting autologous blood clots (length: 1, 2, 3, 4, 5, and 10 cm, n=1 to 3, 14 monkeys in total) into the internal carotid artery of male cynomolgus monkeys. Digital subtraction angiography (DSA) and neurologic deficit observation were performed pre-; immediately after (DSA only); and 1, 3, 6, and 24 h after embolization, and the relationship between clot length, neurologic deficits, and cerebral infarction was assessed.

Results: DSA confirmed MCA occlusion in all animals after the clot injection. Recanalization of the MCA was observed within 6 h post-embolization in animals with shorter clots (≤3 cm). Neurologic deficits were evident in animals with MCA occlusion and correlated with the clot length. Larger clots (≥5 cm) led to permanent MCA occlusion, significant neurologic deficits, and extensive cerebral infarction. Histopathological examination revealed ischemic damage in brain regions corresponding to the infarcted areas.

Conclusion: Clot length is critical in determining the extent of neurologic dysfunction and cerebral infarction, with larger clots producing more severe outcomes. Furthermore, the minimum clot length required for model creation is 5 cm.

背景/目的:缺血性中风是全球关注的主要健康问题,开发可靠的动物模型对了解其病理生理学至关重要。本研究评估了急性非人灵长类血栓栓塞性中风模型中脑血管造影结果与神经功能障碍之间的关系,并确定了适合大脑中动脉(MCA)闭塞的最小血块长度:将自体血块(长度:1、2、3、4、5 和 10 厘米,n=1 至 3,共 14 只猴)注入雄性绒猴的颈内动脉,建立血栓栓塞性脑卒中模型。分别在栓塞前、栓塞后(仅数字减影血管造影)、栓塞后1、3、6和24小时进行数字减影血管造影(DSA)和神经功能缺损观察,并评估血块长度、神经功能缺损和脑梗塞之间的关系:结果:DSA证实所有动物在注射血块后都出现了MCA闭塞。在血块较短(≤3厘米)的动物中,栓塞后6小时内即可观察到MCA再通。MCA闭塞的动物出现明显的神经功能缺损,这与血块的长度有关。较大的血块(≥5厘米)会导致MCA永久性闭塞、明显的神经功能缺损和大面积脑梗塞。组织病理学检查显示,与梗死区域相对应的脑区存在缺血性损伤:结论:血块长度是决定神经功能障碍和脑梗塞程度的关键,血块越大,后果越严重。此外,创建模型所需的最小血块长度为 5 厘米。
{"title":"Cerebral Angiography and Neurobehavioral Patterns in a Non-human Primate Middle Cerebral Artery Occlusion Model.","authors":"Tetsuya Yoshikawa, Yuki Akiyoshi, Kensei Motokawa, Koichiro Nojiri, Hiroaki Kawaguchi","doi":"10.21873/invivo.13689","DOIUrl":"10.21873/invivo.13689","url":null,"abstract":"<p><strong>Background/aim: </strong>Ischemic stroke is a major health concern globally and developing reliable animal models is crucial for understanding its pathophysiology. This study evaluated the relationship between cerebral angiographic findings and neurologic dysfunction in an acute non-human primate thromboembolic stroke model and determined the minimum clot length for suitable middle cerebral artery (MCA) occlusion.</p><p><strong>Materials and methods: </strong>A thromboembolic stroke model was developed by injecting autologous blood clots (length: 1, 2, 3, 4, 5, and 10 cm, n=1 to 3, 14 monkeys in total) into the internal carotid artery of male cynomolgus monkeys. Digital subtraction angiography (DSA) and neurologic deficit observation were performed pre-; immediately after (DSA only); and 1, 3, 6, and 24 h after embolization, and the relationship between clot length, neurologic deficits, and cerebral infarction was assessed.</p><p><strong>Results: </strong>DSA confirmed MCA occlusion in all animals after the clot injection. Recanalization of the MCA was observed within 6 h post-embolization in animals with shorter clots (≤3 cm). Neurologic deficits were evident in animals with MCA occlusion and correlated with the clot length. Larger clots (≥5 cm) led to permanent MCA occlusion, significant neurologic deficits, and extensive cerebral infarction. Histopathological examination revealed ischemic damage in brain regions corresponding to the infarcted areas.</p><p><strong>Conclusion: </strong>Clot length is critical in determining the extent of neurologic dysfunction and cerebral infarction, with larger clots producing more severe outcomes. Furthermore, the minimum clot length required for model creation is 5 cm.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2245-2253"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Injection Site Reactions of Aprepitant and Fosaprepitant in Gynecologic Cancer Chemotherapy. 比较阿瑞匹坦和福沙匹坦在妇科癌症化疗中的注射部位反应
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13704
Seira Nishibe-Toyosato, Yosuke Ando, Yutaka Torii, Ryoko Ichikawa, Akiko Owaki, Hironori Miyamura, Eiji Nishio, Hidezo Matsuda, Naho Tsujii-Fujii, Akane Shimato-Isobe, Kotone Mukaiji, Kaori Ito, Takahiro Hayashi, Takuma Fujii, Shigeki Yamada

Background/aim: The frequency rate of injection site reactions (ISR) due to fosaprepitant meglumine (Fos APR) has been shown to vary depending on the types of combined anticancer drug. This study aimed to elucidate the impact of Fos APR on ISR in patients receiving paclitaxel and carboplatin, with and without bevacizumab therapy (TC±Bev).

Patients and methods: This study focused on patients with gynecologic cancer (n=93) who received TC±Bev administration at Fujita Health University Hospital from March 2016 to February 2020, and monitored up to six cycles. The patients were randomly assigned to the Fos APR group (n=47) and the Aprepitant (APR) group (n=46). Using Visual Infusion Phlebitis (VIP) scores, ISR was evaluated by comparing the VIP scores of all cycles using a linear mixed model. The risk factors that contribute to the occurrence of vascular pain throughout all cycles were also examined.

Results: The VIP scores of all cycles showed a near significant intergroup difference (p=0.071). Factors that affected the development of vascular pain included Fos APR and age (p=0.027 and 0.049, respectively). Regarding age, patients aged <65 years had a higher risk. Four patients underwent a switch from the originally assigned neurokinin-1 receptor antagonist; in all of these cases, Fos APR was changed to APR for vascular pain.

Conclusion: Fos APR may increase the risk for ISR associated with TC±Bev therapy for gynecological cancer.

背景/目的:研究表明,福沙匹坦葡甲胺(Fos APR)引起的注射部位反应(ISR)的发生率因联合抗癌药物的类型而异。本研究旨在阐明 Fos APR 对接受紫杉醇和卡铂治疗及未接受贝伐单抗治疗(TC±Bev)患者 ISR 的影响:本研究主要针对2016年3月至2020年2月期间在富士田保健大学医院接受TC±Bev治疗的妇科癌症患者(n=93),并对其进行了长达6个周期的监测。患者被随机分配到 Fos APR 组(n=47)和 Aprepitant (APR) 组(n=46)。使用可视输液静脉炎(VIP)评分,通过线性混合模型比较所有周期的VIP评分来评估ISR。此外,还研究了导致所有周期发生血管疼痛的风险因素:结果:所有周期的 VIP 评分均显示出近乎显著的组间差异(P=0.071)。影响血管痛发生的因素包括 Fos APR 和年龄(分别为 p=0.027 和 0.049)。结论Fos APR 可能会增加与 TC±Bev 治疗妇科癌症相关的 ISR 风险。
{"title":"Comparing Injection Site Reactions of Aprepitant and Fosaprepitant in Gynecologic Cancer Chemotherapy.","authors":"Seira Nishibe-Toyosato, Yosuke Ando, Yutaka Torii, Ryoko Ichikawa, Akiko Owaki, Hironori Miyamura, Eiji Nishio, Hidezo Matsuda, Naho Tsujii-Fujii, Akane Shimato-Isobe, Kotone Mukaiji, Kaori Ito, Takahiro Hayashi, Takuma Fujii, Shigeki Yamada","doi":"10.21873/invivo.13704","DOIUrl":"10.21873/invivo.13704","url":null,"abstract":"<p><strong>Background/aim: </strong>The frequency rate of injection site reactions (ISR) due to fosaprepitant meglumine (Fos APR) has been shown to vary depending on the types of combined anticancer drug. This study aimed to elucidate the impact of Fos APR on ISR in patients receiving paclitaxel and carboplatin, with and without bevacizumab therapy (TC±Bev).</p><p><strong>Patients and methods: </strong>This study focused on patients with gynecologic cancer (n=93) who received TC±Bev administration at Fujita Health University Hospital from March 2016 to February 2020, and monitored up to six cycles. The patients were randomly assigned to the Fos APR group (n=47) and the Aprepitant (APR) group (n=46). Using Visual Infusion Phlebitis (VIP) scores, ISR was evaluated by comparing the VIP scores of all cycles using a linear mixed model. The risk factors that contribute to the occurrence of vascular pain throughout all cycles were also examined.</p><p><strong>Results: </strong>The VIP scores of all cycles showed a near significant intergroup difference (p=0.071). Factors that affected the development of vascular pain included Fos APR and age (p=0.027 and 0.049, respectively). Regarding age, patients aged <65 years had a higher risk. Four patients underwent a switch from the originally assigned neurokinin-1 receptor antagonist; in all of these cases, Fos APR was changed to APR for vascular pain.</p><p><strong>Conclusion: </strong>Fos APR may increase the risk for ISR associated with TC±Bev therapy for gynecological cancer.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2374-2382"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric Cancer in the Lesser and Greater Curvature: A Comparative Analysis from a Single Western Center. 小弯和大弯胃癌:来自一家西方中心的对比分析
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13709
Nicola Natalizi, Luigina Graziosi, Annibale Donini

Background/aim: To date, the different clinicopathological characteristics of gastric cancer (GC) in the lesser curvature and greater curvature remain unclear. The aim of this study was to investigate the different features of the tumors in the two sites and provide new strategy for a tailored therapy.

Patients and methods: Between January 2003 and December 2019, 121 patients with GC located in the lesser or greater curvature were surgically treated with curative intent. Data about clinico-pathological features were retrospectively analyzed. In addition, we analyzed the different lymph node patterns according to the lymph node (LN) metastasis between the two groups of patients.

Results: No statistically significant differences were found regarding the 5-year overall survival (5y-OS) and 5y disease-free survival (5y-DFS) between patients with GC in the two sites (p=0.94 and p=0.98, respectively). Considering TNM pathological stage, patients with GC in the lesser curvature in stage II and III, showed a worse survival than those with GC in the greater curvature (stage II 5y-OS: 80 vs. 100% and stage III 5y-OS: 18.9 vs. 55.5%). Considering the median value of metastasis LNs, GC in the greater curvature metastasized more often to LN stations no. 8, 10, and 11, whereas GC in the lesser curvature to LN stations no. 8, 9, and 12.

Conclusion: GC in the lesser curvature showed a worse prognosis than GC in the greater curvature. Therefore, GC in the lesser curvature could undergo a more aggressive surgery, including an extended lymphadenectomy, and a close follow-up.

背景/目的:迄今为止,小弯胃癌(GC)和大弯胃癌(GC)的不同临床病理特征仍不清楚。本研究旨在调查这两个部位肿瘤的不同特征,并为定制治疗提供新策略:2003年1月至2019年12月期间,121名位于小弯或大弯的GC患者接受了治愈性手术治疗。我们对临床病理特征数据进行了回顾性分析。此外,我们还根据两组患者淋巴结(LN)转移情况分析了不同的淋巴结模式:结果:两组 GC 患者的 5 年总生存率(5y-OS)和 5 年无病生存率(5y-DFS)差异无统计学意义(P=0.94 和 P=0.98)。考虑到 TNM 病理分期,小弯处 GC 患者在 II 期和 III 期的生存率低于大弯处 GC 患者(II 期 5y-OS: 80 vs. 100%,III 期 5y-OS: 18.9 vs. 55.5%)。考虑到转移淋巴结的中位值,大弯处的 GC 更常转移到第 8、10 和 11 号淋巴结站。从转移淋巴结的中位值来看,曲率较大的 GC 更常转移到第 8、10 和 11 号淋巴结站,而曲率较小的 GC 则转移到第 8、9 和 12 号淋巴结站。结论:结论:小弯 GC 的预后比大弯 GC 差。结论:小弯 GC 的预后比大弯 GC 差,因此,小弯 GC 可以接受更积极的手术,包括扩大淋巴结切除术,并进行密切随访。
{"title":"Gastric Cancer in the Lesser and Greater Curvature: A Comparative Analysis from a Single Western Center.","authors":"Nicola Natalizi, Luigina Graziosi, Annibale Donini","doi":"10.21873/invivo.13709","DOIUrl":"10.21873/invivo.13709","url":null,"abstract":"<p><strong>Background/aim: </strong>To date, the different clinicopathological characteristics of gastric cancer (GC) in the lesser curvature and greater curvature remain unclear. The aim of this study was to investigate the different features of the tumors in the two sites and provide new strategy for a tailored therapy.</p><p><strong>Patients and methods: </strong>Between January 2003 and December 2019, 121 patients with GC located in the lesser or greater curvature were surgically treated with curative intent. Data about clinico-pathological features were retrospectively analyzed. In addition, we analyzed the different lymph node patterns according to the lymph node (LN) metastasis between the two groups of patients.</p><p><strong>Results: </strong>No statistically significant differences were found regarding the 5-year overall survival (5y-OS) and 5y disease-free survival (5y-DFS) between patients with GC in the two sites (p=0.94 and p=0.98, respectively). Considering TNM pathological stage, patients with GC in the lesser curvature in stage II and III, showed a worse survival than those with GC in the greater curvature (stage II 5y-OS: 80 vs. 100% and stage III 5y-OS: 18.9 vs. 55.5%). Considering the median value of metastasis LNs, GC in the greater curvature metastasized more often to LN stations no. 8, 10, and 11, whereas GC in the lesser curvature to LN stations no. 8, 9, and 12.</p><p><strong>Conclusion: </strong>GC in the lesser curvature showed a worse prognosis than GC in the greater curvature. Therefore, GC in the lesser curvature could undergo a more aggressive surgery, including an extended lymphadenectomy, and a close follow-up.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2410-2414"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363746/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemifacial Microsomia Surgical Approach and Anotia Reconstruction: A Case Report. 半面小畸形手术方法和无趾重建术:病例报告。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13729
Aikaterini Bini, Spyridoula Derka, Spyridon Stavrianos

Background/aim: Hemifacial microsomia (HFM) is the second most common congenital anomaly of the craniomaxillofacial region after the cleft lip and palate. This malformation is characterized by unilateral mandible and ear hypoplasia. Treatment varies and depends on different phenotypes. Severe deficiencies require multiple reconstructive surgeries to address facial asymmetries. This study aimed to review the surgical approach and evaluate the postoperative results of a case with right hemifacial microsomia and anotia.

Case report: This is the case of a 35-year-old female patient who, after multiple graft operations in the right mandible due to hemifacial microsomia, was operated for auricle reconstruction. Initially, a three-dimensional custom made Medpor (porex) was used, covered by the superficial temporal fascia. Subsequently, due to inflammation and partial exposure of this porous polyethylene implant (PPI), a temporalis muscular flap along with the deep temporal fascia were used as a salvage operation. Ten months later, the patient underwent deep plane face lift combined with open rhinoplasty. Lefort I osteotomies and transoral lip lengthening through a transection of the levator nasi septi muscle were also performed. Ear helix reconstruction was completed with a rotation scalp flap after tissue expansion. The patient had an uncomplicated postoperative course with an aesthetically acceptable result.

Conclusion: As a congenital disorder, hemifacial microsomia is present at birth and successful reconstruction is of fundamental importance for the smooth integration of these individuals into society. The multiple asymmetries, the affected topographic area of the face, as well as the onset in neonatal age constitute a challenge for reconstructive surgery.

背景/目的:半面神经小畸形(HFM)是继唇腭裂之后颅颌面部第二大最常见的先天性畸形。这种畸形的特点是单侧下颌骨和耳朵发育不良。治疗方法各不相同,取决于不同的表型。严重的缺陷需要进行多次整形手术来解决面部不对称问题。本研究旨在回顾一例右半脸小畸形和无牙症患者的手术方法并评估术后效果:这是一例 35 岁女性患者的病例,她因半颜面小畸形导致右下颌骨多次移植手术后,接受了耳廓重建手术。最初使用的是三维定制的 Medpor(porex),由颞浅筋膜覆盖。随后,由于炎症和多孔聚乙烯假体(PPI)的部分暴露,使用了颞肌皮瓣和颞深筋膜作为挽救手术。十个月后,患者接受了深平面面部提升术和开放式鼻整形术。此外,还进行了 Lefort I 截骨术和通过横断鼻中隔提肌进行的经口嘴唇延长术。耳螺旋重建是在组织扩张后使用旋转头皮瓣完成的。患者的术后过程并不复杂,术后效果美观可接受:作为一种先天性疾病,半面小畸形在出生时就已存在,成功的重建对于这些患者顺利融入社会至关重要。面部的多处不对称、受影响的地形区域以及在新生儿期发病,都对整形手术构成了挑战。
{"title":"Hemifacial Microsomia Surgical Approach and Anotia Reconstruction: A Case Report.","authors":"Aikaterini Bini, Spyridoula Derka, Spyridon Stavrianos","doi":"10.21873/invivo.13729","DOIUrl":"10.21873/invivo.13729","url":null,"abstract":"<p><strong>Background/aim: </strong>Hemifacial microsomia (HFM) is the second most common congenital anomaly of the craniomaxillofacial region after the cleft lip and palate. This malformation is characterized by unilateral mandible and ear hypoplasia. Treatment varies and depends on different phenotypes. Severe deficiencies require multiple reconstructive surgeries to address facial asymmetries. This study aimed to review the surgical approach and evaluate the postoperative results of a case with right hemifacial microsomia and anotia.</p><p><strong>Case report: </strong>This is the case of a 35-year-old female patient who, after multiple graft operations in the right mandible due to hemifacial microsomia, was operated for auricle reconstruction. Initially, a three-dimensional custom made Medpor (porex) was used, covered by the superficial temporal fascia. Subsequently, due to inflammation and partial exposure of this porous polyethylene implant (PPI), a temporalis muscular flap along with the deep temporal fascia were used as a salvage operation. Ten months later, the patient underwent deep plane face lift combined with open rhinoplasty. Lefort I osteotomies and transoral lip lengthening through a transection of the levator nasi septi muscle were also performed. Ear helix reconstruction was completed with a rotation scalp flap after tissue expansion. The patient had an uncomplicated postoperative course with an aesthetically acceptable result.</p><p><strong>Conclusion: </strong>As a congenital disorder, hemifacial microsomia is present at birth and successful reconstruction is of fundamental importance for the smooth integration of these individuals into society. The multiple asymmetries, the affected topographic area of the face, as well as the onset in neonatal age constitute a challenge for reconstructive surgery.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2550-2556"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Ionization Chamber Characteristics for Ultrahigh-dose-rate Scanned Carbon-ion Beams. 超高剂量率扫描碳离子束电离室特性研究
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13686
Noriaki Hamatani, Masashi Yagi, Shinichi Shimizu, Naoki Ishino, Masaki Shimizu, Yoshiaki Kuwana, Toshiro Tsubouchi, Masaaki Takashina, Takuto Miyoshi, Takuya Nomura, Takashi Toyoda, Masumi Umezawa, Teiji Nishio, Masahiko Koizumi, Kazuhiko Ogawa, Tatsuaki Kanai

Background/aim: There are only a few studies on dosimetry with ultrahigh-dose-rate (uHDR) scanned carbon-ion beams. This study investigated the characteristics of four types of ionization chambers for the uHDR beam.

Materials and methods: We employed a newly developed large-plane parallel chamber to monitor a 208.3-MeV/u uHDR scanned carbon-ion beam with a 110-Gy/s average dose rate. The ionization chambers used were the Advanced Markus chamber (AMC), PinPoint 3D chamber (PPC), Farmer chamber (FC), and large-plane parallel chamber (StingRay). The AMC and StingRay surfaces and the PPC and FC geometric centers were aligned to the radiation isocenter using treatment room lasers. Using the voltage range stated in the instruction manuals, we obtained the saturation curves of the chambers. From these curves, we obtained the ion recombination correction factors using the two-voltage and three-voltage linear methods. The dose linearity was evaluated using five measurement points, and the chamber repeatability was verified by conducting repeated measurements for different dose values.

Results: Although all chambers, except for AMC, reached saturation when specified voltages were applied, they exhibited excellent linearity for different dose values. The ion recombination correction factors of the AMC obtained using the aforementioned linear methods were nearly 1. Additionally, all chambers exhibited excellent repeatability. Although the standard deviation of the PPC for the lowest dose was ~1.5%, those of all the other chambers were <1.0%.

Conclusion: All ionization chambers can be used for measuring the relative dose, and absolute dose can be conveniently measured using the AMC with an uHDR carbon-ion scanned beam.

背景/目的:关于超高剂量率(uHDR)扫描碳离子束剂量测定的研究为数不多。本研究调查了用于超高剂量率碳离子束的四种电离室的特性:我们采用了新开发的大平面平行室来监测平均剂量率为 110-Gy/s 的 208.3-MeV/u uHDR 扫描碳离子束。使用的电离室包括先进马库斯电离室(AMC)、PinPoint 3D 电离室(PPC)、Farmer 电离室(FC)和大平面平行电离室(StingRay)。AMC 和 StingRay 表面以及 PPC 和 FC 的几何中心均使用治疗室激光对准辐射等中心。使用说明书中规定的电压范围,我们获得了腔室的饱和曲线。根据这些曲线,我们使用两电压和三电压线性法获得了离子重组校正因子。使用五个测量点对剂量线性进行了评估,并通过对不同剂量值进行重复测量来验证箱体的可重复性:结果:尽管除 AMC 外,所有腔室在施加指定电压时都达到了饱和状态,但它们在不同剂量值下都表现出良好的线性。使用上述线性方法获得的 AMC 离子重组校正因子接近 1。此外,所有样品室都具有出色的重复性。虽然最低剂量的 PPC 标准偏差约为 1.5%,但所有其他电离室的标准偏差均为结论:所有电离室都可用于测量相对剂量,使用超高分辨光束碳离子扫描的 AMC 可以方便地测量绝对剂量。
{"title":"Investigation of Ionization Chamber Characteristics for Ultrahigh-dose-rate Scanned Carbon-ion Beams.","authors":"Noriaki Hamatani, Masashi Yagi, Shinichi Shimizu, Naoki Ishino, Masaki Shimizu, Yoshiaki Kuwana, Toshiro Tsubouchi, Masaaki Takashina, Takuto Miyoshi, Takuya Nomura, Takashi Toyoda, Masumi Umezawa, Teiji Nishio, Masahiko Koizumi, Kazuhiko Ogawa, Tatsuaki Kanai","doi":"10.21873/invivo.13686","DOIUrl":"10.21873/invivo.13686","url":null,"abstract":"<p><strong>Background/aim: </strong>There are only a few studies on dosimetry with ultrahigh-dose-rate (uHDR) scanned carbon-ion beams. This study investigated the characteristics of four types of ionization chambers for the uHDR beam.</p><p><strong>Materials and methods: </strong>We employed a newly developed large-plane parallel chamber to monitor a 208.3-MeV/u uHDR scanned carbon-ion beam with a 110-Gy/s average dose rate. The ionization chambers used were the Advanced Markus chamber (AMC), PinPoint 3D chamber (PPC), Farmer chamber (FC), and large-plane parallel chamber (StingRay). The AMC and StingRay surfaces and the PPC and FC geometric centers were aligned to the radiation isocenter using treatment room lasers. Using the voltage range stated in the instruction manuals, we obtained the saturation curves of the chambers. From these curves, we obtained the ion recombination correction factors using the two-voltage and three-voltage linear methods. The dose linearity was evaluated using five measurement points, and the chamber repeatability was verified by conducting repeated measurements for different dose values.</p><p><strong>Results: </strong>Although all chambers, except for AMC, reached saturation when specified voltages were applied, they exhibited excellent linearity for different dose values. The ion recombination correction factors of the AMC obtained using the aforementioned linear methods were nearly 1. Additionally, all chambers exhibited excellent repeatability. Although the standard deviation of the PPC for the lowest dose was ~1.5%, those of all the other chambers were <1.0%.</p><p><strong>Conclusion: </strong>All ionization chambers can be used for measuring the relative dose, and absolute dose can be conveniently measured using the AMC with an uHDR carbon-ion scanned beam.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2220-2227"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lack of RAMP1 Signaling Suppresses Liver Regeneration and Angiogenesis Following Partial Hepatectomy in Mice. 小鼠部分肝切除术后,缺乏 RAMP1 信号传导会抑制肝脏再生和血管生成。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13691
Shuji Nakamoto, Yoshiya Ito, Nobuyuki Nishizawa, Y U Kuroda, Kanako Hosono, Mariko Kamata, Kazutake Tsujikawa, Yusuke Kumamoto, Hideki Amano

Background/aim: The liver effectively restores both size and function following partial hepatectomy (PHx). Angiogenesis is crucial for the repair and regeneration of liver tissue post-PHx. Calcitonin gene-related peptide (CGRP) released from sensory nerves and its receptor-receptor activity-modifying protein 1 (RAMP1) are involved in angiogenesis. This study aimed to assess the role of RAMP1 signaling in angiogenesis during liver regeneration following PHx.

Materials and methods: RAMP1 deficient (RAMP1-/-) and wild-type (WT) mice were subjected to PHx.

Results: RAMP1-/- mice demonstrated delayed liver regeneration, indicated by lower liver-to-body weight ratios compared to WT mice. This was associated with lower levels of Ki67+ hepatocytes and hepatic trophic growth factors. Additionally, RAMP1-/- mice exhibited lower levels of endothelial cell markers, including CD31, compared to WT mice. This reduction was associated with reduced levels of vascular endothelial growth factor (VEGF)-C, VEGF-D, and VEGF receptor 3 (VEGFR3). In WT mice with PHx, the administration of a VEGFR3 inhibitor reduced the liver-to-body weight ratio, Ki67+ hepatocytes, and VEGF-C/VEGFR3 expression levels in the liver compared to those in the vehicle-treated group.

Conclusion: The deletion of RAMP1 signaling suppresses liver regeneration and angiogenesis through VEGFR3. Specific activation of RAMP1 signaling may represent a potential therapeutic strategy for liver regeneration following PHx.

背景/目的:肝部分切除术(PHx)后,肝脏可有效恢复大小和功能。血管生成对肝切除术后肝组织的修复和再生至关重要。感觉神经释放的降钙素基因相关肽(CGRP)及其受体-受体活性修饰蛋白1(RAMP1)参与了血管生成。本研究旨在评估RAMP1信号在PHx后肝脏再生过程中血管生成的作用:对RAMP1缺失(RAMP1-/-)和野生型(WT)小鼠进行PHx试验:结果:与 WT 小鼠相比,RAMP1-/- 小鼠的肝脏再生延迟,表现为肝脏与体重之比降低。这与 Ki67+ 肝细胞和肝营养生长因子水平较低有关。此外,与 WT 小鼠相比,RAMP1-/- 小鼠表现出较低的内皮细胞标记物水平,包括 CD31。这种降低与血管内皮生长因子(VEGF)-C、VEGF-D 和血管内皮生长因子受体 3(VEGFR3)水平的降低有关。在患有 PHx 的 WT 小鼠中,与药物治疗组相比,服用 VEGFR3 抑制剂可降低肝脏与体重的比率、Ki67+ 肝细胞和肝脏中 VEGF-C/VEGFR3 的表达水平:结论:删除 RAMP1 信号可通过 VEGFR3 抑制肝脏再生和血管生成。特异性激活 RAMP1 信号可能是 PHx 后肝脏再生的一种潜在治疗策略。
{"title":"Lack of RAMP1 Signaling Suppresses Liver Regeneration and Angiogenesis Following Partial Hepatectomy in Mice.","authors":"Shuji Nakamoto, Yoshiya Ito, Nobuyuki Nishizawa, Y U Kuroda, Kanako Hosono, Mariko Kamata, Kazutake Tsujikawa, Yusuke Kumamoto, Hideki Amano","doi":"10.21873/invivo.13691","DOIUrl":"10.21873/invivo.13691","url":null,"abstract":"<p><strong>Background/aim: </strong>The liver effectively restores both size and function following partial hepatectomy (PHx). Angiogenesis is crucial for the repair and regeneration of liver tissue post-PHx. Calcitonin gene-related peptide (CGRP) released from sensory nerves and its receptor-receptor activity-modifying protein 1 (RAMP1) are involved in angiogenesis. This study aimed to assess the role of RAMP1 signaling in angiogenesis during liver regeneration following PHx.</p><p><strong>Materials and methods: </strong>RAMP1 deficient (RAMP1<sup>-/-</sup>) and wild-type (WT) mice were subjected to PHx.</p><p><strong>Results: </strong>RAMP1<sup>-/-</sup> mice demonstrated delayed liver regeneration, indicated by lower liver-to-body weight ratios compared to WT mice. This was associated with lower levels of Ki67<sup>+</sup> hepatocytes and hepatic trophic growth factors. Additionally, RAMP1<sup>-/-</sup> mice exhibited lower levels of endothelial cell markers, including CD31, compared to WT mice. This reduction was associated with reduced levels of vascular endothelial growth factor (VEGF)-C, VEGF-D, and VEGF receptor 3 (VEGFR3). In WT mice with PHx, the administration of a VEGFR3 inhibitor reduced the liver-to-body weight ratio, Ki67<sup>+</sup> hepatocytes, and VEGF-C/VEGFR3 expression levels in the liver compared to those in the vehicle-treated group.</p><p><strong>Conclusion: </strong>The deletion of RAMP1 signaling suppresses liver regeneration and angiogenesis through VEGFR3. Specific activation of RAMP1 signaling may represent a potential therapeutic strategy for liver regeneration following PHx.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2261-2270"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363762/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipopolysaccharide Derived from Pantoea agglomerans Directly Promotes the Migration of Human Keratinocytes. 盘尾丝菌产生的脂多糖直接促进人类角质形成细胞的迁移
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13680
Hiroyuki Inagawa, Takashi Nishizawa, Chie Kohchi, Gen-Ichiro Soma

Background/aim: Because the skin is exposed to the external environment, it is important that wound healing processes proceed and terminate rapidly to minimize the risk of infection. A previous case report described the promotion of wound healing by transdermal administration of lipopolysaccharide derived from Pantoea agglomerans (LPSp). However, whether the wound healing-promoting effect of LPSp was due to direct activity on skin cells or indirect effects involving macrophages remained unclear. Therefore, this study investigated the wound healing-promoting effect of LPSp, particularly the promotion of keratinocyte migration.

Materials and methods: The migration of HaCaT human keratinocytes over time with and without LPSp was assayed using a cell migration assay kit. Migration was also analyzed using HaCaT cells treated with LPSp and an antibody against Toll-like receptor (TLR) 4, a receptor for LPS.

Results: Addition of LPSp significantly enhanced cell migration compared to no LPSp addition. Migration was inhibited by the addition of anti-TLR4 antibody.

Conclusion: LPSp acts directly on epidermal cells to promote migration and may be one mechanism by which LPSp promotes wound healing.

背景/目的:由于皮肤暴露在外部环境中,因此伤口愈合过程必须迅速进行和结束,以最大限度地降低感染风险。之前的一份病例报告描述了通过透皮给药从盘尾丝菌(Pantoea agglomerans)中提取的脂多糖(LPSp)促进伤口愈合的情况。然而,LPSp 促进伤口愈合的作用是直接作用于皮肤细胞,还是间接作用于巨噬细胞,目前仍不清楚。因此,本研究探讨了 LPSp 的伤口愈合促进作用,尤其是促进角质细胞迁移的作用:使用细胞迁移检测试剂盒检测了有 LPSp 和无 LPSp 时 HaCaT 人角质形成细胞的迁移情况。此外,还使用经 LPSp 和 LPS 受体 Toll 样受体 (TLR) 4 抗体处理的 HaCaT 细胞对迁移进行了分析:结果:与不添加 LPSp 相比,添加 LPSp 能明显增强细胞迁移。结论:LPSp 可直接作用于表皮:结论:LPSp 直接作用于表皮细胞以促进迁移,这可能是 LPSp 促进伤口愈合的机制之一。
{"title":"Lipopolysaccharide Derived from <i>Pantoea agglomerans</i> Directly Promotes the Migration of Human Keratinocytes.","authors":"Hiroyuki Inagawa, Takashi Nishizawa, Chie Kohchi, Gen-Ichiro Soma","doi":"10.21873/invivo.13680","DOIUrl":"10.21873/invivo.13680","url":null,"abstract":"<p><strong>Background/aim: </strong>Because the skin is exposed to the external environment, it is important that wound healing processes proceed and terminate rapidly to minimize the risk of infection. A previous case report described the promotion of wound healing by transdermal administration of lipopolysaccharide derived from Pantoea agglomerans (LPSp). However, whether the wound healing-promoting effect of LPSp was due to direct activity on skin cells or indirect effects involving macrophages remained unclear. Therefore, this study investigated the wound healing-promoting effect of LPSp, particularly the promotion of keratinocyte migration.</p><p><strong>Materials and methods: </strong>The migration of HaCaT human keratinocytes over time with and without LPSp was assayed using a cell migration assay kit. Migration was also analyzed using HaCaT cells treated with LPSp and an antibody against Toll-like receptor (TLR) 4, a receptor for LPS.</p><p><strong>Results: </strong>Addition of LPSp significantly enhanced cell migration compared to no LPSp addition. Migration was inhibited by the addition of anti-TLR4 antibody.</p><p><strong>Conclusion: </strong>LPSp acts directly on epidermal cells to promote migration and may be one mechanism by which LPSp promotes wound healing.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 5","pages":"2172-2178"},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
In vivo
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1